Preliminary data suggest that HPV 6, 11, 16, 18, 31, or 33 may be detected in genital tract specimens of at least 50% sexually active women, and in perhaps as much as 20% of sexually inexperienced girls. HPV 6 or 16 DNA has also been detected in samples of normal oral epithelium in 35% to 40% of adults and 10% of children. In addition, over 2/3 of sexually experienced women and 1/3 of sexually inexperienced women were found to have antibodies to HPV 6 L1 antigen. Implications of these data are the following: 1) presumed genital types of HPV are ubiquitous and commonly transmitted by non-sexual contact; 2) HPV genital infection is usually subclinical; 3) other factors influence the epithelial manifestation of HPV infection; and/or 4) evolving PCR and serologic methods are less than 100% specific. To address these questions, a prospective study of 500 randomly selected, sexually inexperienced, university freshman women, 17 to 19 years of age is proposed. Women will be followed over the course of their four year education with tri-annual examinations that include genital tract, oral and blood specimens for detection of presumed genital HPVs by PCR, Southern and dot blot, serologic assay, cytology, and colposcopy. At each visit, women will complete a standardized gynecologic history and clinical examination. Women who become sexually active (estimated to be 85%) will be asked to undergo an additional examination within one week of their sexual debut and women who report establishing a monogamous sexual relationship will be asked to have their male partner examined for evidence of HPV infection. Conceptually, this project is an extension of Project 1, which investigates risk of perinatal and childhood acquisition of HPV, and of Project 3 which will examine several aspects of the humoral immune response over time and relation to other measures of HPV infection. Information gained in Project 4 on the pathogenesis of HPV infection of human keratinocytes in the presence of chemical carcinogens or growth modulators will suggest strategies for the analysis and interpretation of data collected in Projects 1-3.

Project Start
Project End
Budget Start
Budget End
Support Year
3
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
075524595
City
Seattle
State
WA
Country
United States
Zip Code
98109
Watts, D H; Koutsky, L A; Holmes, K K et al. (1998) Low risk of perinatal transmission of human papillomavirus: results from a prospective cohort study. Am J Obstet Gynecol 178:365-73
Carter, J J; Koutsky, L A; Wipf, G C et al. (1996) The natural history of human papillomavirus type 16 capsid antibodies among a cohort of university women. J Infect Dis 174:927-36
Hagensee, M E; Carter, J J; Wipf, G C et al. (1995) Immunization of mice with HPV vaccinia virus recombinants generates serum IgG, IgM, and mucosal IgA antibodies. Virology 206:174-82
Ostrow, R S; Coughlin, S M; McGlennen, R C et al. (1995) Serological and molecular evidence of rhesus papillomavirus type 1 infections in tissues from geographically distinct institutions. J Gen Virol 76 ( Pt 2):293-9
Baken, L A; Koutsky, L A; Kuypers, J et al. (1995) Genital human papillomavirus infection among male and female sex partners: prevalence and type-specific concordance. J Infect Dis 171:429-32
Xi, L F; Demers, G W; Koutsky, L A et al. (1995) Analysis of human papillomavirus type 16 variants indicates establishment of persistent infection. J Infect Dis 172:747-55
Carter, J J; Hagensee, M B; Lee, S K et al. (1994) Use of HPV 1 capsids produced by recombinant vaccinia viruses in an ELISA to detect serum antibodies in people with foot warts. Virology 199:284-91
McDougall, J K (1994) Immortalization and transformation of human cells by human papillomavirus. Curr Top Microbiol Immunol 186:101-19
Xi, L F; Demers, W; Kiviat, N B et al. (1993) Sequence variation in the noncoding region of human papillomavirus type 16 detected by single-strand conformation polymorphism analysis. J Infect Dis 168:610-7
Merrick, D T; Gown, A M; Halbert, C L et al. (1993) Human papillomavirus-immortalized keratinocytes are resistant to the effects of retinoic acid on terminal differentiation. Cell Growth Differ 4:831-40

Showing the most recent 10 out of 17 publications